{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:35:58Z","timestamp":1793709358057,"version":"4.6.1"},"reference-count":46,"publisher":"American Society for Microbiology","issue":"11","license":[{"start":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T00:00:00Z","timestamp":1793664000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T00:00:00Z","timestamp":1793664000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/501100000023","name":"Government of Canada","doi-asserted-by":"publisher","award":["Genome Research and Development Initiative Shared Priority Project: Subproject 2.3"],"award-info":[{"award-number":["Genome Research and Development Initiative Shared Priority Project: Subproject 2.3"]}],"id":[{"id":"10.13039\/501100000023","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Microbiol Spectr"],"published-print":{"date-parts":[[2026,11,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Treatment of healthcare-associated infections is becoming increasingly challenging due to rising antimicrobial resistance (AMR). As clinical microbiology and public health continue to transition toward whole-genome sequencing (WGS) for outbreak detection, diagnostics, and surveillance, the ability to accurately predict antimicrobial resistance from genomic sequence data will become crucial. In this study,\n                      <jats:italic toggle=\"yes\">in silico<\/jats:italic>\n                      antimicrobial resistance prediction with the Staramr tool was refined from whole-genome sequencing data for four top-priority healthcare-associated bacteria: carbapenemase-producing\n                      <jats:italic toggle=\"yes\">Escherichia coli<\/jats:italic>\n                      , carbapenemase-producing\n                      <jats:italic toggle=\"yes\">Klebsiella pneumoniae<\/jats:italic>\n                      , methicillin-resistant\n                      <jats:italic toggle=\"yes\">Staphylococcus aureus<\/jats:italic>\n                      , and vancomycin-resistant\n                      <jats:italic toggle=\"yes\">Enterococcus faecium<\/jats:italic>\n                      . Isolates (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 4,876) were collected in Canada within two national surveillance programs: the Canadian Nosocomial Infection Surveillance Program and the Canadian Ward Study. Broth microdilution was used as the gold standard to evaluate the performance of Staramr. The average sensitivity, specificity, and concordance of categorical antimicrobial resistance prediction compared to broth microdilution were 90.8%, 90.1%, and 92.4% for\n                      <jats:italic toggle=\"yes\">E. coli<\/jats:italic>\n                      (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 1,095); 87.7%, 91.7%, and 90.6% for\n                      <jats:italic toggle=\"yes\">K. pneumoniae<\/jats:italic>\n                      (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 687); 95.5%, 98.9%, and 96.3% for methicillin-resistant\n                      <jats:italic toggle=\"yes\">S. aureus<\/jats:italic>\n                      (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 2,150); and 95.4%, 97.9%, and 97.2% for vancomycin-resistant\n                      <jats:italic toggle=\"yes\">Enterococcus faecium<\/jats:italic>\n                      (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 944). Additionally, this internal tool refinement identified areas of improvement for antimicrobial resistance prediction. The average sensitivity, specificity, and concordance of antimicrobial resistance prediction were high (&gt;90%) for most combinations of antimicrobials and species that were evaluated. While AMR prediction from WGS was very promising, it did not correlate well with current Clinical and Laboratory Standards Institute breakpoints for non-susceptibility for some antimicrobial-organism combinations. As\n                      <jats:italic toggle=\"yes\">in silico<\/jats:italic>\n                      prediction of antimicrobial resistance has been improved in this study through tool refinement, it shows future promise for molecular methods to complement phenotypic antimicrobial susceptibility testing. This will allow for more precise tracking of the molecular epidemiology of resistance and cost savings when isolates are being sequenced for strain typing.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>IMPORTANCE<\/jats:title>\n                    <jats:p>\n                      <jats:italic toggle=\"yes\">In silico<\/jats:italic>\n                      prediction of antimicrobial non-susceptibility in priority healthcare pathogens is becoming an important area of study due to the rising rates of resistance and the transition to whole-genome sequencing. To evaluate whether Staramr, an antimicrobial resistance (AMR) prediction tool, can reliably detect non-susceptibility in four top-priority healthcare-associated bacteria, we performed a validation study on a large Canadian clinical data set, which included carbapenemase-producing\n                      <jats:italic toggle=\"yes\">Escherichia coli<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">Klebsiella pneumoniae<\/jats:italic>\n                      , methicillin-resistant\n                      <jats:italic toggle=\"yes\">Staphylococcus aureus,<\/jats:italic>\n                      and vancomycin-resistant\n                      <jats:italic toggle=\"yes\">Enterococcus<\/jats:italic>\n                      . Compared to traditional antimicrobial susceptibility testing, we found that Staramr was reliable for predicting non-susceptibility for most combinations of antimicrobials and organisms; however, some combinations require additional data on genetic mechanisms of resistance for accurate prediction. Additionally, this study identified areas for refinement for current drug-gene interpretation keys. Thus, this tool refinement study advances the use of genotypic methods of AMR prediction for high-priority healthcare pathogens.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1128\/spectrum.01652-26","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:00:42Z","timestamp":1791280842000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":0,"title":["Genomic prediction of antimicrobial resistance in priority healthcare pathogens using Staramr"],"prefix":"10.1128","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7143-3853","authenticated-orcid":true,"given":"MacKenzie A. P.","family":"Wilke","sequence":"first","affiliation":[{"name":"National Microbiology Laboratory, Public Health Agency of Canada","place":["Winnipeg, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8014-1107","authenticated-orcid":true,"given":"Laura F.","family":"Mataseje","sequence":"additional","affiliation":[{"name":"National Microbiology Laboratory, Public Health Agency of Canada","place":["Winnipeg, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7914-9198","authenticated-orcid":true,"given":"Nicole","family":"Lerminiaux","sequence":"additional","affiliation":[{"name":"National Microbiology Laboratory, Public Health Agency of Canada","place":["Winnipeg, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"McCracken","sequence":"additional","affiliation":[{"name":"National Microbiology Laboratory, Public Health Agency of Canada","place":["Winnipeg, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romaine","family":"Edirmanasinghe","sequence":"additional","affiliation":[{"name":"National Microbiology Laboratory, Public Health Agency of Canada","place":["Winnipeg, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Baxter","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02gfys938","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Medical Microbiology and Infectious Diseases, University of Manitoba","place":["Winnipeg, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Fakharuddin","sequence":"additional","affiliation":[{"name":"National Microbiology Laboratory, Public Health Agency of Canada","place":["Winnipeg, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurman","family":"Grewal","sequence":"additional","affiliation":[{"name":"National Microbiology Laboratory, Public Health Agency of Canada","place":["Winnipeg, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao Rui","family":"Li","sequence":"additional","affiliation":[{"name":"National Microbiology Laboratory, Public Health Agency of Canada","place":["Winnipeg, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Marnier","sequence":"additional","affiliation":[{"name":"National Microbiology Laboratory, Public Health Agency of Canada","place":["Winnipeg, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Petkau","sequence":"additional","affiliation":[{"name":"National Microbiology Laboratory, Public Health Agency of Canada","place":["Winnipeg, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Mulvey","sequence":"additional","affiliation":[{"name":"National Microbiology Laboratory, Public Health Agency of Canada","place":["Winnipeg, Canada"]},{"id":[{"id":"https:\/\/ror.org\/02gfys938","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Medical Microbiology and Infectious Diseases, University of Manitoba","place":["Winnipeg, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3238-0082","authenticated-orcid":true,"given":"George","family":"Zhanel","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02gfys938","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Medical Microbiology and Infectious Diseases, University of Manitoba","place":["Winnipeg, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George R.","family":"Golding","sequence":"additional","affiliation":[{"name":"National Microbiology Laboratory, Public Health Agency of Canada","place":["Winnipeg, Canada"]},{"id":[{"id":"https:\/\/ror.org\/02gfys938","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Medical Microbiology and Infectious Diseases, University of Manitoba","place":["Winnipeg, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4171-9436","authenticated-orcid":true,"given":"Amrita","family":"Bharat","sequence":"additional","affiliation":[{"name":"National Microbiology Laboratory, Public Health Agency of Canada","place":["Winnipeg, Canada"]},{"id":[{"id":"https:\/\/ror.org\/02gfys938","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Medical Microbiology and Infectious Diseases, University of Manitoba","place":["Winnipeg, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_4_2_2","unstructured":"Health Canada. 2017. Tackling antimicrobial resistance and antimicrobial use: a pan-Canadian framework for action. Available from: https:\/\/www.canada.ca\/en\/health-canada\/services\/publications\/drugs-health-products\/tackling-antimicrobial-resistance-use-pan-canadian-framework-action.html"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02724-0"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01082-24"},{"key":"e_1_3_4_5_2","unstructured":"United Kingdom Review on Antimicrobial Resistance. 2014. Antimicrobial resistance: tackling a crisis for the health and wealth of nations. Available from: https:\/\/amr-review.org\/sites\/default\/files\/AMR%20Review%20Paper%20-%20Tackling%20a%20crisis%20for%20the%20health%20and%20wealth%20of%20nations_1.pdf"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0330128"},{"key":"e_1_3_4_7_2","unstructured":"McDonnell A Countryman A Laurence T Gulliver S Drake T Edwards S Kenny C Lamberti O Morton A Shafira A Smith R Guzman J. 2024. Forecasting the fallout from AMR: economic impacts of antimicrobial resistance in humans. Center for Global Development."},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(25)00118-5"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.14745\/ccdr.v49i05a09"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkz283"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaf265"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10020292"},{"key":"e_1_3_4_13_2","unstructured":"Centre for Genomic Epidemiology. 2026. ResFinder database. Available from: https:\/\/bitbucket.org\/genomicepidemiology\/resfinder_db\/src\/master"},{"key":"e_1_3_4_14_2","unstructured":"Centre for Genomic Epidemiology. 2025. PointFinder database. Available from: https:\/\/bitbucket.org\/genomicepidemiology\/pointfinder_db\/src\/master"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx217"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa345"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02412-14"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.12688\/wellcomeopenres.14826.1"},{"key":"e_1_3_4_19_2","unstructured":"Centre for Genomic Epidemiology. 2025. PlasmidFinder database. Available from: https:\/\/bitbucket.org\/genomicepidemiology\/plasmidfinder_db\/src\/master"},{"key":"e_1_3_4_20_2","volume-title":"Performance standards for antimicrobial susceptibility testing","author":"CLSI","year":"2025","unstructured":"CLSI. 2025. CLSI supplement M100. In Performance standards for antimicrobial susceptibility testing, 35th ed. Clinical and laboratory standards institute.","edition":"35"},{"key":"e_1_3_4_21_2","volume-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically","author":"CLSI","year":"2024","unstructured":"CLSI. 2024. CLSI guideline, standard or supplement M07. In Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 12th ed. Clinical and laboratory standards institute.","edition":"12"},{"key":"e_1_3_4_22_2","unstructured":"FDA. 2023. Center for Drug Evaluation and Research (CDER). Tigecycline \u2013 injection product."},{"key":"e_1_3_4_23_2","unstructured":"EUCAST. 2024. Clinical breakpoints and dosing of antibiotics. European Committee on Antimicrobial Susceptibility Testing. https:\/\/www.eucast.org\/clinical_breakpoints."},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1099\/mgen.0.001415"},{"key":"e_1_3_4_25_2","unstructured":"Seemann T. 2017. Shovill: faster SPAdes assembly of Illumina reads. GitHub. Available from: https:\/\/github.com\/tseemann\/shovill"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-023-01940-w"},{"key":"e_1_3_4_27_2","unstructured":"R Core Team. 2024. R: a language and environment for statistical computing. R Foundation for Statistical Computing. https:\/\/www.R-project.org."},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00483-19"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac920"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00310-15"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.46700-0"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2019.00242"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00207-11"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01310-13"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11111632"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00138-20"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1469-0691.2003.00790.x"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkz090"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.00798"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx204"},{"key":"e_1_3_4_41_2","unstructured":"Antimicrobial Resistance Division (AMR) Global Antimicrobial Resistance Surveillance System (GLASS). 2021. GLASS: the detection and reporting of colistin resistance. World Health Organization. Available from: https:\/\/www.who.int\/publications\/i\/item\/glass-the-detection-and-reporting-of-colistin-resistance-2nd-ed"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.038083-0"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2014.05.021"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01513-10"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1128\/jb.00148-25"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-022-04527-z"},{"key":"e_1_3_4_47_2","unstructured":"AMRverse. 2025. AMRrules. Python. GitHub. Available from: https:\/\/github.com\/AMRverse\/AMRrules"}],"container-title":["Microbiology Spectrum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.01652-26","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.01652-26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:05:15Z","timestamp":1793707515000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/spectrum.01652-26"}},"subtitle":[],"editor":[{"given":"Silvia T.","family":"Cardona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,11,3]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11,3]]}},"alternative-id":["10.1128\/spectrum.01652-26"],"URL":"https:\/\/doi.org\/10.1128\/spectrum.01652-26","relation":{},"ISSN":["2165-0497"],"issn-type":[{"value":"2165-0497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,11,3]]},"assertion":[{"value":"2026-06-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01652-26"}}